3172 results for «393»

Filter By

3172 results

Challenging CTO Cases - Session 1

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about a complex challenging case of left main bifurcation disease and ostial left anterior descending CTO, as well as a rotational atherectomy assisted-PCI for an old calcified CTO, and more!

Challenging CTO Cases - Session 1

Left main and multivessel disease - Session 2

15 Dec 2022 – From GulfPCR-GIM 2022

View a sudden LM stem occlusion, a LM dissection during CTO, or even a rotablation in LM triple vessel disease in severe left ventricle dysfunction, and much more in this GulfPCR-GIM 2022 session.

Left main and multivessel disease - Session 2

Challenging TAVI scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!

Challenging TAVI scenarios

Challenging CTO cases - Session 2

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.

Challenging CTO cases - Session 2

Bifurcation lesion - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!

Bifurcation lesion - Tools, devices and techniques

The why and how of performing a successful TAVI case

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.

The why and how of performing a successful TAVI case

CTO - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn how a left anterior descending in-stent CTO was rescued by epicardial retrograde wiring, how a guidewire was redirected using a dual lumen microcath, how a CTO intervention was treated in an anomalous right coronary artery, and more!

CTO - Tools, devices and techniques

Challenging ACS scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...

Challenging ACS scenarios

PCI in stable CAD

14 Dec 2022 – From GulfPCR-GIM 2022

Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.

PCI in stable CAD

Bifurcation lesion

14 Dec 2022 – From GulfPCR-GIM 2022

Among the 3 bifurcation lesion cases presented in this GulfPCR-GIM 2022 session, find out how to deliver a trapped guidewire, how to manage a live angioplasty that turned out to be a nightmare, and how to deal with a multivessel intervention with left main bifurcation and...

Bifurcation lesion

Left main multivessel disease and other coronary interventions

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!

Left main multivessel disease and other coronary interventions

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening
Didn’t find what you were looking for?